
Kiora Pharmaceuticals Reports First Quarter Results Initiating Two Phase 2 Trials For Treatment Of Retinal Diseases ...
(MENAFN- Newsfile Corp) Encinitas, California--(Newsfile Corp. - May 9, 2025) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced first quarter 2025 financial results and provided an update on its …